146 related articles for article (PubMed ID: 16698578)
1. Effects of hemoglobin concentration on hyperdynamic circulation associated with portal hypertension.
Hua R; Cao H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):215-8. PubMed ID: 16698578
[TBL] [Abstract][Full Text] [Related]
2. Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension.
Cirera I; Elizalde JI; Piqué JM; Feu F; Casadevall M; Goldin E; Terés J; Bosch J; Rodés J
Dig Dis Sci; 1997 Aug; 42(8):1697-702. PubMed ID: 9286236
[TBL] [Abstract][Full Text] [Related]
3. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined splenorenal shunt devascularization and devascularization only on hemodynamics of the portal venous system in patients with portal hypertension.
Cao H; Hua R; Wu ZY
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):385-8. PubMed ID: 16109521
[TBL] [Abstract][Full Text] [Related]
5. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
7. Systemic hemodynamic changes in mansonic schistosomiasis with portal hypertension treated by azygoportal disconnection and splenectomy.
de Cleva R; Pugliese V; Zilberstein B; Saad WA; Pinotti HW; Laudanna AA
Am J Gastroenterol; 1999 Jun; 94(6):1632-7. PubMed ID: 10364036
[TBL] [Abstract][Full Text] [Related]
8. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
9. [Influence of anemia on hemodynamic changes in patients with cirrhosis].
Denié C; Poynard T; Gadano A; Vachiery F; Soupison T; Elman A; Valla D; Moreau R; Lebrec D
Gastroenterol Clin Biol; 1997; 21(1):29-33. PubMed ID: 9091387
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.
Chang PE; Miquel R; Blanco JL; Laguno M; Bruguera M; Abraldes JG; Bosch J; Garcia-Pagan JC
Am J Gastroenterol; 2009 Jul; 104(7):1707-14. PubMed ID: 19471257
[TBL] [Abstract][Full Text] [Related]
11. Effects of different infusion volumes on hemodynamics of portal hypertension canines after hemorrhagic shock.
Li XQ; Dong L; Luo JY
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):571-6. PubMed ID: 15567747
[TBL] [Abstract][Full Text] [Related]
12. [Hyperdynamic circulation in Manson's hepatosplenic schistosomiasis].
de Cleva R; Pugliese V; Zilberstein B; Saad WA; Pinotti HW; Laudanna AA
Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(1):6-10. PubMed ID: 9659736
[TBL] [Abstract][Full Text] [Related]
13. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of pulmonary hypertension in patients with hepatosplenic Mansonic schistosomiasis--prospective study.
de Cleva R; Herman P; Pugliese V; Zilberstein B; Saad WA; Rodrigues JJ; Laudanna AA
Hepatogastroenterology; 2003; 50(54):2028-30. PubMed ID: 14696458
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome.
Blei AT; Mazhar S; Davidson CJ; Flamm SL; Abecassis M; Gheorghiade M
J Clin Gastroenterol; 2007; 41 Suppl 3():S323-9. PubMed ID: 17975484
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of risk factors for selective devascularization in patients with portal hypertension].
Cao YJ; Xie M; Bao SH; Pan YM; Xu BY
Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(1):18-20. PubMed ID: 18509995
[TBL] [Abstract][Full Text] [Related]
17. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the Fibrotest and portal hypertension in patients with liver disease.
Thabut D; Imbert-Bismut F; Cazals-Hatem D; Messous D; Muntenau M; Valla DC; Moreau R; Poynard T; Lebrec D
Aliment Pharmacol Ther; 2007 Aug; 26(3):359-68. PubMed ID: 17635370
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase in hyperdynamic portal hypertensive rats.
Cao H; Xu J; Hua R; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):252-6. PubMed ID: 16698586
[TBL] [Abstract][Full Text] [Related]
20. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
